首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Shrinking the room for invasive ventilation in hypercapnic respiratory failure
【24h】

Shrinking the room for invasive ventilation in hypercapnic respiratory failure

机译:在高碳酸血症性呼吸衰竭中缩小有创通气空间

获取原文
           

摘要

Abstract: Noninvasive ventilation (NIV) was introduced as an alternative to invasive mechanical ventilation for acute respiratory failure caused from exacerbations of chronic obstructive pulmonary disease in the 1980s, and its use gradually rose worldwide. Seventy-eight patients (57 males, mean age 78.3 ± 9.2 years) undergoing NIV were evaluated. Of them, 48 (62.3%) had acute hypercapnic respiratory failure because of a chronic obstructive pulmonary disease exacerbation, and the remaining 30 had acute hypercapnic respiratory failure from other causes, mainly cardiac failure. All patients were treated by NIV using the bi-level positive airway pressure set up at high pressure/high backup rate. NIV was successful in 67 subjects (85.9%) and the patients were discharged, 57 of whom continued NIV at home and ten had spontaneous breathing. NIV was unsuccessful in eleven patients, ten of whom died and one was successfully treated by invasive mechanical ventilation. Significant differences were detected for a higher basal Glasgow Coma Scale score in successfully treated patients (P = 0.007), a higher basal Acute Physiology and Chronic Health Evaluation score in unsuccessfully treated patients (P = 0.004), and a lower pH after 1 hour in unsuccessfully treated patients (P = 0.015). These findings show a very high rate of success of NIV in patients with acute hypercapnic respiratory failure not only from chronic obstructive pulmonary disease but also from cardiac failure. This suggests that the use of invasive mechanical ventilation may be further reduced, with a decrease in its known complications as well.
机译:摘要:在1980年代,无创通气(NIV)被引入作为有创机械通气的替代方法,用于治疗因慢性阻塞性肺疾病加重而引起的急性呼吸衰竭,并且在世界范围内逐渐普及。对接受NIV的78例患者(57例男性,平均年龄78.3±9.2岁)进行了评估。其中,48例(62.3%)由于慢性阻塞性肺疾病加重而导致急性高碳酸血症性呼吸衰竭,其余30例由其他原因引起的急性高碳酸血症性呼吸衰竭,主要是心力衰竭。所有患者均采用高/后备率双水平气道正压通气治疗。 NIV在67名受试者(85.9%)中成功完成,患者出院,其中57人在家继续进行NIV,十名自主呼吸。 NIV未成功治疗11例患者,其中10例死亡,其中1例通过有创机械通气成功治疗。在成功治疗的患者中,较高的基础格拉斯哥昏迷量表评分(P = 0.007),未成功治疗的患者中的基础急性生理和慢性健康评估评分较高(P = 0.004)以及在治疗1小时后的pH值较低,差异有统计学意义。未成功治疗的患者(P = 0.015)。这些发现表明,不仅由于慢性阻塞性肺疾病而且由于心力衰竭,急性高碳酸血症性呼吸衰竭患者的NIV成功率很高。这表明可以进一步减少有创机械通气的使用,并减少已知并发症的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号